GT
DPLO

Glenmede Trust’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Glenmede Trust’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-420
Closed -$1K – 2760
2020
Q1 		$1K Hold
420
– – ﹤0.01% 2980
2019
Q4 		$1K Hold
420
– – ﹤0.01% 2980
2019
Q3 		$2 Buy
420
+268
+176% +$1.5K ﹤0.01% 2893
2019
Q2 		$0 Hold
152
– – ﹤0.01% 3253
2019
Q1 		$0 Hold
152
– – ﹤0.01% 3241
2018
Q4 		$2 Buy
+152
New +$2.56K ﹤0.01% 2823

Glenmede Trust's DPLO Position: Q2 2020 in Review

Glenmede Trust sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2020, closing a stake of 420 shares — an estimated $1K sold.

Glenmede Trust first reported a position in DPLO in Q4 2018 and held it in 6 quarters. The position peaked at $1K in Q1 2020. 0 funds tracked by Wall St. Rank hold DPLO as of Q2 2020.

  • Glenmede Trust reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2020 after selling out during the quarter.
  • Glenmede Trust sold 420 DIPLOMAT PHARMACY, INC. shares in Q2 2020, an estimated $1K.
  • Glenmede Trust first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2018 and held it in 6 quarters.
  • Glenmede Trust's DIPLOMAT PHARMACY, INC. position peaked at $1K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2020.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.